Bisphosphonates for Patients Diagnosed With Multiple Myeloma

    loading  Checking for direct PDF access through Ovid

Abstract

Clinical Question

Among patients with multiple myeloma, is bisphosphonate therapy associated with lower rates of mortality, vertebral fractures, nonvertebral fractures, and skeletal-related events compared with placebo or no treatment?

Bottom Line

Among patients with myeloma, bisphosphonates were associated with lower rates of pathological fractures and skeletal-related events compared with placebo or no treatment. Direct meta-analysis showed no association between bisphosphonates and mortality. In network meta-analysis, zoledronate was associated with lower risk of mortality compared with placebo or no treatment.

Related Topics

    loading  Loading Related Articles